MX2018008953A - Composiciones que comprenden 2fl y lnnt para usar en infantes o niños pequeños para prevenir la obesidad en la vida posterior o comorbilidades relacionadas. - Google Patents

Composiciones que comprenden 2fl y lnnt para usar en infantes o niños pequeños para prevenir la obesidad en la vida posterior o comorbilidades relacionadas.

Info

Publication number
MX2018008953A
MX2018008953A MX2018008953A MX2018008953A MX2018008953A MX 2018008953 A MX2018008953 A MX 2018008953A MX 2018008953 A MX2018008953 A MX 2018008953A MX 2018008953 A MX2018008953 A MX 2018008953A MX 2018008953 A MX2018008953 A MX 2018008953A
Authority
MX
Mexico
Prior art keywords
lnnt
infants
compositions
young children
related comorbidities
Prior art date
Application number
MX2018008953A
Other languages
English (en)
Inventor
Favre Laurent
Sprenger Norbert
NEMBRINI Chiara
BINIA Aristea
Manuel RAMOS NIEVES José
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2018008953A publication Critical patent/MX2018008953A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Pediatric Medicine (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La presente invención se refiere a una composición nutritiva que comprende al menos un oligosacárido fucosilado y al menos un oligosacárido N-acetilado para usar a fin de reducir y/o evitar la acumulación excesiva de masa grasa en un infante o un niño pequeño y/o para usar a fin de prevenir trastornos de la salud relacionados en la vida posterior, como obesidad en la vida posterior y comorbilidades relacionadas.
MX2018008953A 2016-01-26 2017-01-26 Composiciones que comprenden 2fl y lnnt para usar en infantes o niños pequeños para prevenir la obesidad en la vida posterior o comorbilidades relacionadas. MX2018008953A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16152747 2016-01-26
PCT/EP2017/051593 WO2017129650A1 (en) 2016-01-26 2017-01-26 Compositions comprising 2fl and lnnt for use in infants or young children to prevent later in life obesity or related comorbidities

Publications (1)

Publication Number Publication Date
MX2018008953A true MX2018008953A (es) 2018-09-03

Family

ID=55237547

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018008953A MX2018008953A (es) 2016-01-26 2017-01-26 Composiciones que comprenden 2fl y lnnt para usar en infantes o niños pequeños para prevenir la obesidad en la vida posterior o comorbilidades relacionadas.

Country Status (10)

Country Link
US (1) US20190029303A1 (es)
EP (1) EP3407894A1 (es)
CN (1) CN108697721A (es)
AU (1) AU2017211274A1 (es)
BR (1) BR112018013538A2 (es)
CL (1) CL2018001825A1 (es)
MX (1) MX2018008953A (es)
PH (1) PH12018501328A1 (es)
RU (1) RU2018130329A (es)
WO (1) WO2017129650A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10835544B2 (en) 2014-12-08 2020-11-17 Glycom A/S Synthetic composition for regulating satiety
US10987368B2 (en) 2014-12-08 2021-04-27 Glycom A/S Synthetic composition for preventing or treating CVD
US10881674B2 (en) 2014-12-08 2021-01-05 Glycom A/S Synthetic composition for treating metabolic disorders
AU2017211272B2 (en) * 2016-01-26 2022-04-21 Société des Produits Nestlé S.A. Human milk oligosaccharides for health benefits by prevention of premature adiposity rebound
BR112018013534B1 (pt) 2016-01-26 2023-03-07 Société des Produits Nestlé S.A. Uso de 2fl e lnnt para controlar a ingestão de alimentos e o crescimento em bebês ou crianças pequenas, e para promoção de um crescimento saudável de um bebê ou criança pequena
WO2017215721A1 (en) * 2016-06-15 2017-12-21 Glycom A/S Synthetic compositions comprising human milk oligosaccharides for use γν the prevention and treatment of disorders
US20220000892A1 (en) * 2018-11-30 2022-01-06 Societe Des Produits Nestle S.A. Infant nutritional composition for use in the enhancement of pancreatic maturation and insulin biosynthesis
CA3153077A1 (en) * 2019-10-17 2021-04-22 Societe Des Produits Nestle S.A. Extensively hydrolysed infant formula
WO2021105338A1 (en) * 2019-11-27 2021-06-03 Société des Produits Nestlé S.A. Novel composition for reducing stress disorders
WO2021123131A1 (en) * 2019-12-18 2021-06-24 Basf Se Composition for the treatment of hypertension and/or associated morbidities thereto
WO2022118269A1 (en) * 2020-12-04 2022-06-09 Glycom A/S Human milk oligosaccharides for use in supporting maturation or improvement of sleeping patterns
WO2022129556A1 (en) * 2020-12-18 2022-06-23 Société des Produits Nestlé S.A. Compositions for use in promoting accelerated butyrate production in young children
CN112914104B (zh) * 2021-03-08 2021-11-12 合生元（广州）健康产品有限公司 用于预防婴幼儿肥胖的一种营养组合物
WO2023148525A1 (en) * 2022-02-04 2023-08-10 Health And Happiness (H&H) Hong Kong Ltd 2'-fucosyllactose and lacto-n-neotetraose for preventing and treating overweight

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2143341A1 (en) * 2008-07-08 2010-01-13 Nestec S.A. Nutritional Composition Containing Oligosaccharide Mixture
CA2822495C (en) * 2010-12-31 2020-12-22 Abbott Laboratories Methods of using human milk oligosaccharides for improving airway respiratory health
US20160113952A1 (en) * 2013-05-22 2016-04-28 Glycom As Synthetic Mixture of Oligosaccharides for Treating a Microbiota of a Mammal
WO2015085557A1 (en) * 2013-12-12 2015-06-18 Nestec S.A. Array of age-tailored infant formula with optimum protein content and lactose content
CN106714583A (zh) * 2014-09-25 2017-05-24 雀巢产品技术援助有限公司 具有自适应水平的人乳寡糖(hmo)的婴儿配方食品体系

Also Published As

Publication number Publication date
RU2018130329A (ru) 2020-02-27
WO2017129650A1 (en) 2017-08-03
CN108697721A (zh) 2018-10-23
CL2018001825A1 (es) 2018-08-24
PH12018501328A1 (en) 2019-02-11
RU2018130329A3 (es) 2020-05-18
AU2017211274A1 (en) 2018-05-10
BR112018013538A2 (pt) 2018-12-04
US20190029303A1 (en) 2019-01-31
EP3407894A1 (en) 2018-12-05

Similar Documents

Publication Publication Date Title
PH12018501328A1 (en) Compositions comprising 2fl and lnnt for use in infants or young children to prevent later in life obesity or related comorbidities
PH12018501299A1 (en) Compositions with specific oligosaccharides to prevent later in life obesity or related comorbidities, by increasing colonic scfa production and/or by increasing glp-1 secretion
PH12018501263A1 (en) Compositions comprising sialylated oligosaccharides for use in infants or young children to prevent later in life obesity or related comorbidities and promote a healthy growth
PH12017550041A1 (en) Compositions for use in improving stool consistency or frequency in infants or young children
PH12017550040A1 (en) Compositions for use in the prevention or treatment of gastrointestinal infections/inflammations in infants or young children
PH12018501325A1 (en) Compositions comprising human milk oligosaccharides for use in infants or young children to prevent or treat a health disorder by increasing glp-1 secretion
PH12018501324A1 (en) COMPOSITIONS COMPRISING 2FL AND LNnT TO CONTROL FOOD INTAKE AND GROWTH IN INFANTS OR YOUNG CHILDREN
PH12017550044A1 (en) Compositions for use in the prevention or treatment of otitis or bronchitis in infants or young children
PH12017502350A1 (en) Nutritional compositions with 2fl and lnnt for use in inducing a gut microbiota close to the one of breast fed infants
MX2022013835A (es) Produccion sinergica de butirato asociada con la complejidad de la mezcla de hmo para usar en infantes o niños pequeños en con fines de salud.
PH12020550959A1 (en) Compositions for use in the reduction of nociception in infants and young children
PH12018501262A1 (en) Compositions comprising human milk oligosaccharides for use in infants or young children to prevent or treat allergies
PH12021551077A1 (en) A nutritional composition comprising a combination of human milk oligosaccharides to improve the gastrointestinal barrier
PH12018501298A1 (en) Human milk oligosaccharides for health benefits by prevention of premature adiposity rebound
MX2018015187A (es) Composiciones nutricionales con 2fl y lnnt para su uso en la prevencion y/o tratamiento de la diarrea no causada por rotavirus mediante la accion en la disbiosis de la microbiota intestinal.
PH12019550168A1 (en) Composition comprising human milk oligosaccharides (hmo) for use in the improvement of short term memory and other cognitive benefits
PH12018501297A1 (en) Human milk oligosaccharides against later in life excessive fat mass accumulation and related health disorders
PH12021551071A1 (en) A nutritional composition comprising 6`sl and lnt in combination to improve the gastrointestinal barrier function
ZA202004246B (en) Compositions comprising at least on n-acetylated and at least one fucosylated oligosaccharide for use in the promotion of digestive capacity in infants and young children
PH12015502543A1 (en) Anti-regurgitation composition maintaining gut motility
PH12019500092A1 (en) Nutritional compositions for infants and/or young children comprising oligosaccharides
PH12017500466A1 (en) Nutritional compositions comprising sn-1(3) monoacylglycerols for use in the treatment of growth delay in infants or children
NZ753208A (en) Anti-regurgitation composition maintaining gut motility